Lab Reference Library / Fecal Fat (72-Hour)
Gut & Immune
Fecal Fat (72-Hour)
Fecal Fat · 72-Hour Fecal Fat · Fat Malabsorption TestFecal fat reference ranges and why the 72-hour quantitative fecal fat collection is the gold standard for diagnosing fat malabsorption, distinguishing pancreatic exocrine insufficiency from mucosal absorptive defects, and identifying the fat-soluble nutrient depletion downstream of maldigestion.
Fat MalabsorptionExocrine Pancreas
NormalBelow 7g / day
Mild Malabsorption7 to 14g / day
Severe MalabsorptionAbove 14g / day
Collection72 Hours
← Back to Lab Reference Library
Category: Gut & Immune | Also known as: Fecal Fat, 72-Hour Fecal Fat, Quantitative Stool Fat, Fat Malabsorption Test
1. What This Test Measures
The 72-hour quantitative fecal fat collection measures the total amount of fat excreted in stool over three consecutive days while consuming a standardized 100-gram fat diet. Fat digestion is a sequential, enzyme-dependent process: pancreatic lipase emulsifies dietary triglycerides into fatty acids and monoglycerides; bile acids from the gallbladder emulsify fat droplets into micelles; the intestinal mucosa absorbs those micelles through enterocyte brush borders; and lymphatic chylomicrons transport absorbed fat into circulation. Failure at any stage of this sequence produces fat malabsorption, with undigested fat appearing in stool as steatorrhea.
The 72-hour quantitative collection is the gold standard for fat malabsorption diagnosis because it averages fat excretion across three days, reducing the day-to-day variability inherent in stool testing and quantifying the degree of malabsorption rather than simply detecting its presence. It directly measures the functional consequence of pancreatic exocrine failure, mucosal absorptive disease, or bile acid deficiency, and the degree of elevation distinguishes mild subclinical malabsorption from severe pancreatic insufficiency.
In functional medicine, fecal fat testing is particularly valuable for patients with unexplained weight loss, chronic diarrhea with oily or floating stools, fat-soluble nutrient depletion (vitamins A, D, E, K), or clinical features suggesting pancreatic exocrine insufficiency (chronic pancreatitis history, alcohol excess, diabetes of long duration, or cystic fibrosis). It is complementary to fecal elastase-1, which specifically identifies pancreatic origin of malabsorption.
2. Optimal Range and Clinical Thresholds
| Fecal Fat (g/day) | Interpretation |
|---|---|
| Below 7 g/day | Normal: less than 7% of a 100g fat intake; adequate fat digestion and absorption |
| 7 to 14 g/day | Mild to moderate malabsorption: clinically significant; identify and treat underlying cause |
| 14 to 25 g/day | Moderate to severe malabsorption: substantial fat loss; fat-soluble nutrient depletion expected |
| Above 25 g/day | Severe malabsorption: typically indicates severe pancreatic exocrine insufficiency or significant mucosal disease; urgent evaluation |
The test requires a standardized 100g daily fat diet during the 3-day collection period for accurate interpretation. Under-reporting dietary fat intake falsely lowers the result. Stool must be refrigerated during collection and shipped promptly. Patients should document all foods consumed during the collection period for laboratory reference.
3. Differential Diagnosis: Locating the Malabsorption Defect
| Cause | Mechanism | Distinguishing Features | Confirmatory Test |
|---|---|---|---|
| Pancreatic exocrine insufficiency (PEI) | Insufficient lipase secretion; fat enters small intestine undigested | Oily, pale, foul-smelling stools; may float; history of chronic pancreatitis, alcohol, or diabetes; weight loss | Fecal elastase-1 below 200 mcg/g; CT showing pancreatic atrophy or calcification |
| Celiac disease | Villous atrophy reduces absorptive surface and brush border enzyme expression | Family history; iron deficiency; dermatitis herpetiformis; neurological symptoms; responds to gluten elimination | Anti-tTG IgA, total IgA, small bowel biopsy; HLA-DQ2/DQ8 genetic testing |
| Crohn's disease (ileal) | Ileal inflammation impairs bile acid reabsorption producing bile acid malabsorption; may also reduce absorptive surface | Diarrhea, cramping, weight loss, perianal disease; elevated fecal calprotectin; iron and B12 deficiency | MR enterography, ileoscopy with biopsy, fecal calprotectin |
| Bile acid malabsorption / cholestatic liver disease | Insufficient bile acid pool impairs fat emulsification; micelle formation fails | History of ileal resection, cholestatic liver disease, or chronic diarrhea after cholecystectomy | SeHCAT test (75Se-homocholic acid taurine); bile acid levels in stool |
| Short bowel syndrome | Reduced absorptive surface area from surgical resection | History of intestinal resection; TPN dependence; known short bowel anatomy | Clinical history; small bowel anatomy imaging |
| SIBO with bile salt deconjugation | Bacteria deconjugate bile acids in the small intestine, impairing micellar fat absorption | Bloating, gas, diarrhea, responds to antibiotics; may present with fat-soluble vitamin deficiency | SIBO breath test; empiric rifaximin trial with clinical response monitoring |
4. Fat-Soluble Nutrient Consequences of Chronic Fat Malabsorption
Chronic fat malabsorption produces progressive depletion of every fat-soluble nutrient, with clinical consequences that often present years before the malabsorption is diagnosed. The fat-soluble vitamins A, D, E, and K2 are all absorbed through the same lipid-dependent micellar pathway as dietary fat. When fat malabsorption reduces micellar formation, fat-soluble nutrient absorption falls proportionally regardless of dietary intake. Patients with even moderate fat malabsorption commonly present with osteoporosis (vitamin D and K2 deficiency), night blindness or frequent infections (vitamin A), neuropathy and oxidative stress burden (vitamin E), and coagulopathy or vascular calcification (vitamin K). Essential fatty acid deficiency from impaired fat absorption produces its own syndrome of inflammatory skin conditions, impaired wound healing, and neurological dysfunction.
- Vitamin D: the most clinically consequential fat-soluble deficiency in malabsorption; vitamin D deficiency from malabsorption requires substantially higher supplementation doses than diet-related deficiency because even high oral doses are poorly absorbed without adequate fat digestion; may require 25-hydroxyvitamin D (calcifediol) which is water-soluble and bypasses the lipid absorption deficit; monitor serum 25(OH)D every 3 months
- Vitamin K2 (MK-7): essential for osteocalcin carboxylation directing calcium into bone and for matrix Gla protein activation preventing vascular calcification; K2 deficiency produces paradoxical osteoporosis with vascular calcification; severely underrecognized consequence of fat malabsorption in older adults
- Vitamin A (retinol): essential for mucosal integrity, visual cycle, and immune function; deficiency produces night blindness, increased infection susceptibility, and impaired gut barrier repair; the intestinal permeability that perpetuates Candida and pathogen overgrowth is worsened by vitamin A deficiency
- Vitamin E (tocopherol): the primary lipid-soluble antioxidant protecting cell membranes from oxidative damage; deficiency produces hemolytic anemia, peripheral neuropathy, cerebellar ataxia, and retinopathy in severe cases; oxidative stress burden is elevated in patients with unrecognized vitamin E malabsorption
- Essential fatty acids (omega-3 and omega-6): both EPA/DHA and linoleic acid require lipid absorption; EFA deficiency produces inflammatory skin conditions (eczema, psoriasis flares), impaired wound healing, dry eyes, and neurological symptoms; also impairs prostaglandin production with downstream effects on inflammation regulation and platelet function
5. Treatment by Underlying Cause
Pancreatic Exocrine Insufficiency
- Pancreatic enzyme replacement therapy (PERT): the definitive treatment; lipase is the critical component; standard dosing is 40,000 to 50,000 lipase units (USP) per main meal and 25,000 units per snack; must be taken with the first bite of food, not before or after; inadequate dosing is the most common reason for treatment failure
- Acid suppression: gastric acid inactivates pancreatic enzymes; PPI co-administration optimizes enzyme efficacy by reducing duodenal acid load; particularly important in patients with elevated gastric acid output
- Medium-chain triglycerides (MCTs): MCTs do not require pancreatic lipase or micellar formation for absorption; absorbed directly into the portal circulation; useful as a calorie-dense supplement in patients with severe PEI or as a dietary fat source during enzyme titration
- Alcohol cessation: ongoing alcohol use accelerates pancreatic fibrosis and worsens exocrine insufficiency; absolute cessation is required for disease management in alcohol-related pancreatitis
- Fat-soluble vitamin repletion in all cases: vitamin D (with calcifediol if malabsorption is severe), K2, A, and E should be supplemented and monitored regardless of other treatment
Mucosal and Other Causes
- Celiac disease: strict, lifelong gluten-free diet is the only treatment; mucosal healing and DAO/brush border enzyme restoration typically occurs within 3 to 12 months of strict adherence; fecal fat normalizes as villi recover; serial anti-tTG IgA and fecal fat monitoring confirm response
- Crohn's disease: disease-specific treatment (biologics, immunosuppressants, or surgical resection of strictures) to achieve mucosal remission; fecal fat monitoring alongside calprotectin to track mucosal healing; bile acid sequestrants (cholestyramine) if ileal Crohn's has produced bile acid malabsorption from ileal dysfunction
- SIBO: rifaximin or herbal antimicrobial protocol to eradicate bacterial bile acid deconjugation; bile acid supplementation (ox bile extract) during treatment if bile acid pool is depleted
- Bile acid malabsorption: bile acid sequestrants reduce diarrhea but do not improve fat absorption; ursodeoxycholic acid for cholestatic causes; dietary fat restriction with MCT supplementation for severe cases; ileal resection patients benefit from colesevelam or colestipol
- Supplement all fat-soluble nutrients: regardless of cause, always address downstream nutrient deficiencies concurrently with treating the malabsorption mechanism
6. Related Lab Tests
Fecal Elastase-1Confirms Pancreatic Origin of Fat Malabsorption
→
Vitamin D (25-OH)Primary Fat-Soluble Deficiency Consequence
→
Vitamin AFat-Soluble; Malabsorption Produces Immune and Mucosal Deficiency
→
Vitamin K2Bone and Vascular Consequence of Fat Malabsorption
→
Fecal CalprotectinMucosal Inflammation from Crohn or Celiac Driving Malabsorption
→
SIBO Breath TestSIBO Bile Acid Deconjugation Causes Secondary Fat Malabsorption
→
7. Clinical Perspective
Clinical Perspective
Fat malabsorption is almost always diagnosed later than it should be, primarily because the downstream nutrient deficiencies are treated without investigating their common upstream cause. I have seen patients on calcium and vitamin D supplements for years with worsening osteoporosis who had undiagnosed moderate pancreatic exocrine insufficiency producing fat malabsorption that prevented those supplements from being absorbed. The treatment was not more calcium or a different vitamin D dose. The treatment was fecal elastase testing confirming PEI and initiation of pancreatic enzyme replacement with every meal. Within six months their vitamin D levels normalized on the same supplement dose they had been taking for four years, and their bone density began to recover. The 72-hour fecal fat test is not commonly ordered, which is exactly why it continues to explain a significant proportion of unexplained fat-soluble nutrient deficiencies that no amount of supplementation had corrected.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
8. Frequently Asked Questions
What is normal fecal fat excretion?
Normal fecal fat excretion is below 7 grams per day on a standardized 100g fat diet during the 72-hour collection period. This represents less than 7% fat malabsorption. Values of 7 to 14g per day indicate mild to moderate malabsorption requiring investigation. Values above 14g per day indicate severe malabsorption almost always from pancreatic exocrine insufficiency or significant mucosal disease such as celiac disease.
What causes elevated fecal fat?
The two primary categories are: pancreatic exocrine insufficiency (insufficient lipase secretion from chronic pancreatitis, pancreatic cancer, cystic fibrosis, or diabetes-associated exocrine atrophy) and intestinal mucosal absorptive defects (celiac disease villous atrophy, Crohn disease, short bowel syndrome, Whipple disease). Bile acid deficiency from cholestatic liver disease, ileal resection, or primary bile acid malabsorption also produces fat malabsorption by preventing micelle formation. Fecal elastase-1 distinguishes pancreatic from non-pancreatic causes.
What nutrients are depleted by fat malabsorption?
Chronic fat malabsorption produces progressive depletion of all fat-soluble nutrients: vitamin A (night blindness, immune dysfunction, mucosal integrity failure), vitamin D (osteoporosis, immune dysregulation), vitamin E (neuropathy, hemolytic anemia, oxidative stress), vitamin K2 (osteoporosis and vascular calcification paradox), and essential fatty acids (inflammatory skin conditions, impaired wound healing, neurological dysfunction). These deficiencies accumulate silently over years before clinical consequences appear.
How is fat malabsorption from pancreatic insufficiency treated?
Pancreatic enzyme replacement therapy (PERT) with lipase 40,000 to 50,000 USP units per main meal taken with the first bite of food. Acid suppression (PPI) to protect enzymes from gastric acid inactivation. Medium-chain triglyceride supplementation for calories and as a fat source that bypasses the lipase requirement. Alcohol cessation in alcohol-related pancreatitis. Fat-soluble vitamin repletion with monitoring, using water-soluble vitamin D (calcifediol) if oral lipid-soluble forms are still poorly absorbed on enzyme therapy.
How do I collect a 72-hour fecal fat sample?
Consume a standardized 100g fat diet for all three collection days and document everything eaten. Collect all stool produced over exactly 72 hours in the laboratory-provided sealed container. Keep the container refrigerated throughout collection. Record the start and end times of collection. Ship with ice packs on a Monday or Tuesday to avoid weekend laboratory delays. Avoid changing dietary fat intake during the collection period, as under-eating fat will falsely lower the result.
Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Fat malabsorption means your fat-soluble nutrients are not reaching your bloodstream regardless of what you supplement. The 72-hour fecal fat test locates the defect.
Unexplained fat-soluble vitamin deficiencies that do not respond to supplementation often have a common upstream cause. Schedule a consultation for a complete fat malabsorption evaluation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.